Clinical Trial Update: Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age [Phase 4]

View source ↗

Summary

Phase 4 safety and efficacy comparison of Smoflipid vs Intralipid 20% in pediatric patients (3 months to 16 years) with malnutrition; study terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malnutrition in Children

Drugs mentioned

• Intralipid 20% (intravenous lipid emulsion 20%)
• SMOFLIPID

Snippet

Sponsor: Fresenius Kabi | Conditions: Malnutrition, Child | Phase 4 | Status: TERMINATED | Results posted: 2022-12-12